Skip to content

Role ot rTMS in upper limb neuropathic pain

Value of repetitive transcranial magnetic stimulation (rTMS) in upper extremity neuropathic pain rehabilitation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202505829636417
Enrollment
60
Registered
2025-05-14
Start date
2025-04-05
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases

Interventions

Repetitive transcranial magnetic stimulation
Sham TMS

Sponsors

Asmaa Helmy
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: male or female adult patients (aged 20 years or older) identified using the Neuropathic Pain Grading System as having either probable or definite neuropathic pain Pain involving the upper limb for 6 months or longer, moderate to severe pain according to visual analog scale (VAS) (scale > 45mm) inadequate pain improvement even after taking medications for neuropathic pain.

Exclusion criteria

Exclusion criteria: pregnant patients incapable of filling out the written questionnaires or had a history of dementia, severe aphasia, major psychiatric disorder, epilepsy, complete paralysis of upper limbs. Conditions that preclude rTMS use (e.g. cardiac pacemaker implant)

Design outcomes

Primary

MeasureTime frame
The efficacy of rTMS sessions in improving neuropathic pain in upper limb

Secondary

MeasureTime frame
To improve quality of life , depressive symptoms and cognitive impairment

Countries

Egypt

Contacts

Public ContactWafaa Soliman

Lecturer of physical Medicine Rheumatology and Rehabilitation

Wafaamahmoud880@yahoo.com0201005533968

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026